Funding for this research was provided by:
Qatar University (QUUG-CPH-CPH-12/13-2)
Received: 8 July 2018
Accepted: 26 June 2019
First Online: 24 July 2019
Ethics approval and consent to participate
: The study was approved by Qatar University (QU) Institutional Review Board (QU-IRB 228-E/13), Doha, Qatar and the Robert Gordon University (RGU) School of Pharmacy and Life Sciences Research Ethics Committee (RGU-6-June-2013), Aberdeen UK. Participants were sent participants information leaflet prior to the focus group and all provided us with a written signed consent prior before the focus groups were conducted.
: All participants consented for the research data to be published in an appropriate healthcare journal without identifiable information.
: The authors have no competing interests to declare.